glp-1 and kidneys Antiinflammatory actions of medicines across organs. GLP-1R GLP-1 evidence signals shift in

GLP-1 directly stimulates POMC/CART neurons and indirectly inhibits neuropeptide Y (NPY) and agouti-related peptide (AgRP) to increase measures of satiety and decrease hunger [32]

The evidence is strongest for improvements in weight, BMI, insulin resistance, waist circumference, and some androgen-related markers

Official Journal of the American College of Gastroenterology, 113 (5), 647659

doi: 10.2337/diabetes.52.5.1147

This goes a long way towards making sure that findings are applicable to worldwide populations, rather than just one geography

If progress slows, you can review strategies in Breaking a Weight-Loss Plateau with Semaglutide to help restart progress